Google to the rescue! Canagliflozin, Dapagliflozin, and Empagliflozin, OH MY! That's why I couldn't remember their names, I would never waste brain RAM on a bunch of, pardon the term, Copycat drugs!
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
SGLT2 inhibitors are a class of prescription medicines that are FDA-approved for use with diet and exercise to lower blood sugar in adults with type 2 diabetes. Medicines in the SGLT2 inhibitor class include canagliflozin, dapagliflozin, and empagliflozin. They are available as single-ingredient products and also in combination with other diabetes medicines such as metformin. SGLT2 inhibitors lower blood sugar by causing the kidneys to remove sugar from the body through the urine. The safety and efficacy of SGLT2 inhibitors have not been established in patients with type 1 diabetes, and FDA has not approved them for use in these patients.
